What is the current Genomic Biomarkers Market size?

The Genomic Biomarkers Market is projected to register a CAGR of 9.20% during the forecast period (2024-2029) Read More

Who are the key players in Genomic Biomarkers Market?

Thermo Fisher Scientific Inc. , F. Hoffmann-La Roche Ltd , Myriad Genetics Inc, Eurofins Scientific and QIAGEN are the major companies operating in the Genomic Biomarkers Market. Read More

Which is the fastest growing region in Genomic Biomarkers Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Genomic Biomarkers Market?

In 2024, the North America accounts for the largest market share in Genomic Biomarkers Market. Read More

What years does this Genomic Biomarkers Market cover?

The report covers the Genomic Biomarkers Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Genomic Biomarkers Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Genomic Biomarkers Market Share

Statistics for the 2023 & 2024 Genomic Biomarkers market share, created by Mordor Intelligence™ Industry Reports. Genomic Biomarkers share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Genomic Biomarkers Industry

The Genomic Biomarkers Market is highly competitive owing to the presence of large number of competitors. To sustain and increase footprints in such a competitive landscape, major players are adopting a lot of strategies such as product innovations, expansions, technology upgrades, investments in R&D as well as mergers and acquisitions. In 2018, BioMrieux SA completed the acquisition of Astute Medical to have access to biomarkers in the product pipeline of Astute Medical.

Major players currently in the market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Myriad Genetics Inc, Eurofins Scientific, QIAGEN etc.